Table 2.
Control | Exposure | |
---|---|---|
%dec RR | 51 (18) | 67 (15)* |
Apnea duration, s | 4.5 (8.3) | 7.8 (8.5)* |
No. of apneas | 1.1 (2.7) | 2.2 (4.7)*‡ |
%dec HR | 21 (11) | 28 (14) |
Bradycardia duration, s | 0.2 (0.7) | 0.3 (0.7) |
No. of bradycardias | 0.2 (0.7) | 0.5 (1)† |
Minimum HR, min−1 | 142 (9) | 144 (7) |
%inc MAP | 23 (16) | 18(10) |
Respiratory LCR duration, s | 13.2 (10) | 14.8 (8.8) |
Total Ta EMG duration, s | 2.2 (2.9) | 2.5 (2.9) |
%dec Saturation | 3 (3) | 3 (3) |
Saturation, area under 90% | 0.04 (0.2) | 0.06 (0.3) |
Saturation, area under 85% | 0.01 (0.08) | 0.02 (0.14) |
No. of swallows | 12 (10) | 8 (7)† |
Arousal no. of LCR with arousal/total no. of LCR | 76/89 | 83/116† |
Coughs (no. of LCR with cough/total no. of LCR | 14/94 | 11/116 |
Awakening (no. of LCR with awakening/total no. of LCR) | 48/76 | 55/83 |
Values are means (SD). Results are means from all laryngeal stimulations (all solutions and all states of alertness) for each group. Values in the control group were available only in 5 lambs for percent increase in MAP (%inc MAP) and saturation indexes and in 6 lambs for the number of swallows and total duration of electrical activity of the thyroarytenoid muscle (Ta EMG duration). %dec HR, %dec RR, and %dec saturation, percent decrease in HR, RR, or O2 saturation, respectively; LCR, laryngeal chemoreflexes.
P < 0.05;
P < 0.1 vs. control.
Significant interaction between sleep state and solution (see Table 3 for details).